Merck cans both its COVID19 vaccines due to weak clinical data

Merck has stopped development of its two COVID19 vaccine candidates after getting a look at phase 1 data. The vaccine powerhouse said neither …

  • You already voted!
  • Read More

Get Unlimited Free Access

Join 6,000 other readers who get their news from us